GlassScriptPhysician profile
Maazullah Khan
NPI 1447993142
$2,090.65
in general payments reported to CMS, 2019-2025
10 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $86.46 · 2023: $323 · 2024: $1,341 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206 · Travel and Lodging: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,206.09 |
| Travel and Lodging | $798.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $998.51 | 2024 | Truelok, Truelok System |
| Stryker Corporation | $371.82 | 2023-2025 | Augment Injectable, Invision, Infinity Adaptis |
| Smith+Nephew, INC. | $262.48 | 2022-2025 | Stravix, Renasys Go V2 Home |
| Bioventus LLC | $141.70 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Kci USA, INC. | $101.63 | 2023 | V.A.C. Veraflo |
| Abbvie INC. | $82.88 | 2023 | |
| Bone Support INC. | $68.05 | 2025 | Ceramentbone Void Filler, Cerament G |
| Sobi, INC | $27.27 | 2025 | |
| Ucb, INC. | $21.04 | 2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $15.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maazullah Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.